Becky Cap

Mar 7, 2024 | bioprocessintl.com | Cheryl Scott |Becky Cap |Erica Friedman |K.R. Poudel

With Anne Montgomery’s retirement this past November, I am now the last founder standing on the BPI staff. It began in 2002 as an idea from Brian Caine and Stephanie Schaffer on the business side with Anne and me on the editorial side, and we put out our first issue in January 2003. Now the brand includes conferences in Boston, San Diego, Europe, and Asia; a training academy; an online news outlet; webinars and custom publishing; and of course the publication that you hold in your hands.

Feb 8, 2024 | bioprocessintl.com | Becky Cap

The materials used in cell and gene therapies (CGTs) come from human donors, introducing variability that complicates manufacturing. For consistency in product safety and efficacy, it is critical to address donor variability and optimize manufacturing at every step of CGT production. And that starts before cell collection. Despite its rapid growth, the CGT sector has yet to coalesce robust, evidence-based standards in areas such as cell collection and donor screening.